Quick Links
Topics
-
Recent Posts
Recent Comments
Terry McCormick on “The Best Drug Companies Of The Past 15 Years?”
Mike - I agree with you that the popular press usually misses your point on...Posted Feb 20, 2012Terry McCormick on Examining the “other end” of the Semantics telescope
A recent article in the Wall Street Journal (see link), gives another example of the...Posted Feb 07, 2012Terry McCormick on Automating Serendipity
Watson has a paying client. One of the more exciting directions for healthcare and...Posted Sep 12, 2011
Blogroll
Links
Category Archives: New R&D models
Decentralized R&D the “winning strategy”? – Apple begs to differ
There is a provocative piece in Aug 20 2012 issue (by Connie Guglielmo) of Forbes on Apple’s R&D, countering Pharma (and Tech) trend of decentralizing such efforts. Besides creating many high-level jobs and even more $B, is this creating a … Continue reading
Innovation Upturn? New Medical Entities /$ Increasing!
A recent posting on Derek Lowe’s “In the Pipeline” presents a dismal view of the returns on R&D in Pharma. BCG had included a graph (from Bernstein Research) of the trend of new molecular entities (“nme”) per $B spent over … Continue reading
Another R&D model sea-change?
Reflections on GSK’s new R&D model collaborating with top “academic superstars” Continue reading